Therapy with interferon-α and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells

Journal of Medical Virology

Volumn 80, Issue 6, 2008, Pages 989-996

  Cheng, Pin Nan ^a   Wei, Ya Ling ^a   Chang, Ting Tsung ^a   Chen, Jiann Shiuh ^b   Young, Kung Chia ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Flow cytometry; Interferon ; Interferon stimulated genes; Peripheral blood mononuclear cells; T cell activation

Indexed keywords

ALPHA2B INTERFERON; CD28 ANTIGEN; CD86 ANTIGEN; HLA ANTIGEN; RIBAVIRIN;

ADULT; AGED; ANALYTIC METHOD; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEPATITIS C; HUMAN; MALE; MONOCYTE; MULTIVARIATE ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; UPREGULATION;

ADULT; AGED; ANTIGENS, SURFACE; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RIBAVIRIN; TIME FACTORS; UP-REGULATION;

HEPATITIS C VIRUS;

EID: 43249110705     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21192     Document Type: Article

References (40)

1. Bare P, Massud I, Parodi C, Belmonte L, Garcia G, Nebel MC, Corti M, Pinto MT, Bianco RP, Bracco MM, Campos R, Ares BR. 2005. Continuous release of hepatitis C virus by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients. J Gen Virol 86:1717-1727.
2. Barnes E, Harcourt G, Brown D, Lucas M, Phillips R, Dusheiko G, Klenerman P. 2002. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36:743-754.
3. Bowen DG, Walker CM. 2005. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436:946-952.
4. Chang KM, Thimme R, Melpolder JJ, Oldach D, Pemberton J, Moorhead-Loudis J, McHutchison JG, Alter HJ, Chisari FV. 2001. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 33:267-276.
5. Collins M, Ling V, Carreno BM. 2005. The B7 family of immune-regulatory ligands. Genome Biol 6:223.
6. Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov NV. 2000. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 118:346-355.
7. Freeman AJ, Marinos G, Ffrench RA, Lloyd AR. 2005. Intrahepatic and peripheral blood virus-specific cytotoxic T lymphocyte activity is associated with a response to combination IFN-alpha and ribavirin treatment among patients with chronic hepatitis C virus infection. J Viral Hepat 12:125-129.
8. Gale M Jr, Foy EM. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436:939-945.
9. Hayashi N, Takehara T. 2006. Antiviral therapy for chronic hepatitis C: Past, present, and future. J Gastroenterol 41:17-27.
10. He XS, Rehermann B, Lopez-Labrador FX, Boisvert J, Cheung R, Mumm J, Wedemeyer H, Berenguer M, Wright TL, Davis MM, Greenberg HB. 1999. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 96:5692-5697.
11. Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR. 2005. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42:702-710.
12. Hiasa Y, Takahashi H, Shimizu M, Nuriya H, Tsukiyama-Kohara K, Tanaka T, Horiike N, Onji M, Kohara M. 2004. Major histocompatibility complex class-I presentation impaired in transgenic mice expressing hepatitis C virus structural proteins during dendritic cell maturation. J Med Virol 74:253-261.
13. Hohler T, Gerken G, Notghi A, Knolle P, Lubjuhn R, Taheri H, Schneider PM, Meyer zum Buschenfelde KH, Rittner C. 1997. MHC class II genes influence the susceptibility to chronic active hepatitis C. J Hepatol 27:259-264.
14. Ji X, Cheung R, Cooper S, Li Q, Greenberg HB, He XS. 2003. Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. Hepatology 37:610-621.
15. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, Sasaki Y, Kasahara A, Hori M. 1999. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162:5584-5591.
16. Kikuchi I, Ueda A, Mihara K, Miyanaga O, Machidori H, Ishikawa E, Tamura K. 1998. The effect of HLA alleles on response to interferon therapy in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 10:859-863.
17. Konan KV, Giddings TH Jr, Ikeda M, Li K, Lemon SM, Kirkegaard K. 2003. Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus. J Virol 77:7843-7855.
18. Korenaga M, Hino K, Okita K. 2001. A possible role of human leukocyte antigen(HLA) typing for predicting response to interferon therapy in chronic hepatitis C. Nippon Rinsho 59:1345-1350.
19. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. 1992. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149: 3339-3344.
20. Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, Kaneshige T, Tatsumi T, Ito A, Mochizuki K, Sasaki Y, Kasahara A, Hori M. 1998. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology 27:240-244.
21. Lanford RE, Guerra B, Lee H, Chavez D, Brasky KM, Bigger CB. 2006. Genomic response to interferon-alpha in chimpanzees: Implications of rapid downregulation for hepatitis C kinetics. Hepatology 43:961-972.
22. Lee SD, Yu ML, Cheng PN, Lai MY, Chao YC, Hwang SJ, Chang WY, Chang TT, Hsieh TY, Liu CJ, Chen DS. 2005. Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan. J Viral Hepat 12:283-291.
23. Minton EJ, Smillie D, Neal KR, Irving WL, Underwood JC, James V. 1998. Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J Infect Dis 178:39-44.
24. Miyaguchi S, Saito H, Ebinuma H, Morizane T, Ishii H. 1997. Possible association between HLA antigens and the response to interferon in Japanese patients with chronic hepatitis C. Tissue Antigens 49: 605-611.
25. Nelson DR, Marousis CG, Ohno T, Davis GL, Lau JY. 1998. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. Hepatology 28:225-230.
26. Pal S, Sullivan DG, Kim S, Lai KK, Kae J, Cotler SJ, Carithers RL Jr, Wood BL, Perkins JD, Gretch DR. 2006. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: Implications of HCV lymphotropism. Gastroenterology 130:1107-1116.
27. Patel K, Norris S, Lebeck L, Feng A, Clare M, Pianko S, Portmann B, Blatt LM, Koziol J, Conrad A, McHutchison JG. 2006. HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C. Hepatology 43:241-249.
28. Rehermann B, Chang KM, McHutchinson J, Kokka R, Houghton M, Rice CM, Chisari FV. 1996a. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 70:7092-7102.
29. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. 1996b. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 98:1432-1440.
30. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. 1993. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74:1093-1102.
31. Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM. 2003. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: The apoptotic effects of virus infection. J Virol 77:2134-2146.
32. Tardif KD, Siddiqui A. 2003. Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells. J Virol 77:11644-11650.
33. Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Astemborski J, Carrington M, Thomas DL. 2002. HLA-Cw*04 and hepatitis C virus persistence. J Virol 76:4792-4797.
34. Tillmann HL, Chen DF, Trautwein C, Kliem V, Grundey A, Berning-Haag A, Boker K, Kubicka S, Pastucha L, Stangel W, Manns MP. 2001. Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease. Gut 48:714-718.
35. Vejbaesya S, Songsivilai S, Tanwandee T, Rachaibun S, Chantangpol R, Dharakul T. 2000. HLA association with hepatitis C virus infection. Hum Immunol 61:348-353.
36. Wang LY, Lin HH, Lee TD, Wu YF, Hu CT, Cheng ML, Lo SY. 2005. Human leukocyte antigen phenotypes and hepatitis C viral load. J Clin Virol 32:144-150.
37. Wong DK, Dudley DD, Afdhal NH, Dienstag J, Rice CM, Wang L, Houghton M, Walker BD, Koziel MJ. 1998. Liver-derived CTL in hepatitis C virus infection: Breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol 160:1479-1488.
38. Yu ML, Dai CY, Chen SC, Chiu CC, Lee LP, Lin ZY, Hsieh MY, Wang LY, Chuang WL, Chang WY. 2003. Human leukocyte antigen class I and II alleles and response to interferon-alpha treatment, in Taiwanese patients with chronic hepatitis C virus infection. J Infect Dis 188:62-65.
39. Zanetti M, Castiglioni P, Rizzi M, Wheeler M, Gerloni M. 2004. B lymphocytes as antigen-presenting cell-based genetic vaccines. Immunol Rev 199:264-278.
40. Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C. 2003. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 37:1180-1188.